[go: up one dir, main page]

GB201105979D0 - Novel estrogen receptor ligands - Google Patents

Novel estrogen receptor ligands

Info

Publication number
GB201105979D0
GB201105979D0 GBGB1105979.7A GB201105979A GB201105979D0 GB 201105979 D0 GB201105979 D0 GB 201105979D0 GB 201105979 A GB201105979 A GB 201105979A GB 201105979 D0 GB201105979 D0 GB 201105979D0
Authority
GB
United Kingdom
Prior art keywords
estrogen receptor
receptor ligands
novel estrogen
novel
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1105979.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Healthcare AB
Original Assignee
Karo Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karo Bio AB filed Critical Karo Bio AB
Priority to GBGB1105979.7A priority Critical patent/GB201105979D0/en
Publication of GB201105979D0 publication Critical patent/GB201105979D0/en
Priority to PCT/EP2012/056293 priority patent/WO2012136772A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1105979.7A 2011-04-07 2011-04-07 Novel estrogen receptor ligands Ceased GB201105979D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1105979.7A GB201105979D0 (en) 2011-04-07 2011-04-07 Novel estrogen receptor ligands
PCT/EP2012/056293 WO2012136772A1 (en) 2011-04-07 2012-04-05 Fused pyrrole derivates as estrogen receptor ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1105979.7A GB201105979D0 (en) 2011-04-07 2011-04-07 Novel estrogen receptor ligands

Publications (1)

Publication Number Publication Date
GB201105979D0 true GB201105979D0 (en) 2011-05-18

Family

ID=44072172

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1105979.7A Ceased GB201105979D0 (en) 2011-04-07 2011-04-07 Novel estrogen receptor ligands

Country Status (2)

Country Link
GB (1) GB201105979D0 (en)
WO (1) WO2012136772A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
EP3189026B1 (en) 2014-09-02 2020-07-22 The Regents of The University of California Estrogen receptor ligand treatment for neurodegenerative diseases
CN106278993B (en) * 2015-05-15 2019-05-21 兰州大学 A kind of synthetic method of the polysubstituted pyrrole of gold catalysis
CN107496419B (en) * 2016-06-14 2021-03-23 兰州大学 Cyclopenta [ b ] pyrrole compound with anti-inflammatory activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220377A1 (en) 2002-05-08 2003-11-27 Richard Chesworth Indole compounds and their use as estrogen agonists/antagonists
US7250440B2 (en) 2003-08-12 2007-07-31 Wyeth (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents
EP1889617A1 (en) 2006-07-11 2008-02-20 Freie Universität Berlin Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents
HUE025471T2 (en) * 2008-04-16 2016-03-29 Karobio Ab Novel estrogen receptor ligands

Also Published As

Publication number Publication date
WO2012136772A1 (en) 2012-10-11

Similar Documents

Publication Publication Date Title
GB201103955D0 (en) Antibodies
GB201112056D0 (en) Antibodies
GB0917571D0 (en) Novel estrogen receptor ligands
SG2014012280A (en) Bracket
IL239080A0 (en) Neurotensin receptor ligands
PL2760315T3 (en) Bracket
GB201110973D0 (en) Bracket
IL231518A0 (en) Ep1 receptor ligands
AU337816S (en) Bracket
ZA201400708B (en) Novel estrogen receptor ligands
GB201213822D0 (en) Checkweigher
GB201105979D0 (en) Novel estrogen receptor ligands
ZA201500220B (en) Novel cholecystokinin receptor ligands
EP2714074A4 (en) Anti-emr1 antibodies
HUP1100731A2 (en) Complex forming compounds
GB2496130B (en) Bracket
GB201105984D0 (en) Novel estrogen receptor ligands
GB201105983D0 (en) Novel estrogen receptor ligands
GB201011859D0 (en) Novel estrogen receptor ligands
GB201004377D0 (en) Novel estrogen receptor ligands
GB201013921D0 (en) Novel estrogen receptor ligands
GB201201224D0 (en) Screen for a bandscreen
GB0917575D0 (en) Novel estrogen receptor ligands
GB0917574D0 (en) Novel estrogen receptor ligands
GB201118046D0 (en) Interface bracket

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)